Immunoreactive epidermal growth factor in human amniotic fluid

T. Barka; H. Van Der Noen; E. W. Gresik; T. Kerenyi

Immunoreactive epidermal growth factor in human amniotic fluid

T. Barka
, H. Van Der Noen
, E. W. Gresik
, T. Kerenyi

Research output: Contribution to journal › Article › peer-review

70 Scopus citations

Abstract

Human amniotic fluids, obtained by amniocentesis at 16-24 weeks of gestation, were analyzed for epidermal growth factor (EGF) by using a heterologous radioimmunoassay. The range of EGF in 28 amniotic fluids was 0.06-1 ng/ml. Much higher levels of EGF up to 26 ng/ml, were detected in 3 amniotic fluids. Competitive binding assays and chromatography of concentrated amniotic fluids provided additional evidence for the presence of immunoreactive EGF in amniotic fluid.

Original language	English
Pages (from-to)	679-684
Number of pages	6
Journal	Mount Sinai Journal of Medicine
Volume	45
Issue number	6
State	Published - 1978
Externally published	Yes

Cite this

@article{f884bba11b054d18bce5a32cef89dd36,

title = "Immunoreactive epidermal growth factor in human amniotic fluid",

abstract = "Human amniotic fluids, obtained by amniocentesis at 16-24 weeks of gestation, were analyzed for epidermal growth factor (EGF) by using a heterologous radioimmunoassay. The range of EGF in 28 amniotic fluids was 0.06-1 ng/ml. Much higher levels of EGF up to 26 ng/ml, were detected in 3 amniotic fluids. Competitive binding assays and chromatography of concentrated amniotic fluids provided additional evidence for the presence of immunoreactive EGF in amniotic fluid.",

author = "T. Barka and \{Van Der Noen\}, H. and Gresik, \{E. W.\} and T. Kerenyi",

year = "1978",

language = "English",

volume = "45",

pages = "679--684",

journal = "Mount Sinai Journal of Medicine",

issn = "0027-2507",

publisher = "Ubiquity Press",

number = "6",

}

TY - JOUR

T1 - Immunoreactive epidermal growth factor in human amniotic fluid

AU - Barka, T.

AU - Van Der Noen, H.

AU - Gresik, E. W.

AU - Kerenyi, T.

PY - 1978

Y1 - 1978

N2 - Human amniotic fluids, obtained by amniocentesis at 16-24 weeks of gestation, were analyzed for epidermal growth factor (EGF) by using a heterologous radioimmunoassay. The range of EGF in 28 amniotic fluids was 0.06-1 ng/ml. Much higher levels of EGF up to 26 ng/ml, were detected in 3 amniotic fluids. Competitive binding assays and chromatography of concentrated amniotic fluids provided additional evidence for the presence of immunoreactive EGF in amniotic fluid.

AB - Human amniotic fluids, obtained by amniocentesis at 16-24 weeks of gestation, were analyzed for epidermal growth factor (EGF) by using a heterologous radioimmunoassay. The range of EGF in 28 amniotic fluids was 0.06-1 ng/ml. Much higher levels of EGF up to 26 ng/ml, were detected in 3 amniotic fluids. Competitive binding assays and chromatography of concentrated amniotic fluids provided additional evidence for the presence of immunoreactive EGF in amniotic fluid.

UR - https://www.scopus.com/pages/publications/0018221806

M3 - Article

C2 - 310947

AN - SCOPUS:0018221806

SN - 0027-2507

VL - 45

SP - 679

EP - 684

JO - Mount Sinai Journal of Medicine

JF - Mount Sinai Journal of Medicine

IS - 6

ER -

Immunoreactive epidermal growth factor in human amniotic fluid

Abstract

Fingerprint

Cite this